EUCTR2005-003219-66-GB进行中（未招募）不适用
Allopurinol in the prevention of superficial bladder tumour recurrence - RAPOR study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Allopurinol in the prevention of superficial bladder tumour recurrenceSuperficial transitional cell carcinoma of the urinary bladderCancerISRCTN65811336eicester General Hospital (UK)64
已完成
3 期
The effect of Allopurinol in prevention of contrast induced nephropathy in patients undergoing angioplastyephropathy.Disorder of kidney and ureter, unspecified28.9IRCT20190406043182N1Tabriz University of Medical Sciences100
已完成
2 期
Allopurinol in the prevention of pre-procedural myocardial injury following angioplastyIschemic heart diseases patients.Ischaemic heart diseasesI20, I21,IRCT201412088307N11Vice chancellor for research, Tabriz University of Medical Sciences100
Enrolling By Invitation
3 期
Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trialMust have provided written informed consent prior to any screening procedures.Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure.ERCPTCTR20210814001Srinagarind Hospital Khonkaen University194
已完成
不适用
Effect of allopurinol in preventing kidney damage due to coronary angiographycontrast induced nephropathy.X-ray contrast mediaIRCT2015120525372N1Tehran University of Medical Sciences200